MEGHAN PARKER: Open Payments
NPI 1649035320 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$379 in 17 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $1,906 · 2025 $379
Food & beverage: $379
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 4 | $110 |
| Janssen Pharmaceuticals, Inc | 4 | $96 |
| Axsome Therapeutics, Inc. | 4 | $85 |
| Otsuka America Pharmaceutical, Inc. | 2 | $38 |
| Mannkind Corporation | 1 | $18 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $17 |
| Teva Pharmaceuticals USA, Inc. | 1 | $16 |
Products named: FANAPT, SPRAVATO, Auvelity, REXULTI, AFREZZA, CAPLYTA, AUSTEDO XR.
Industry payments across TX — which companies pay providers there.
